See All Slides - tctmd.com

Slides

Presentation TVT 2015

A Template for Transcatheter Mitral Randomized Trials: Essentials From the Mitral VARC Initiative

Presenter: Paul A. Grayburn, Nicole Ibrahim, David L. Brown, Gregg W. Stone

June 05, 2015

Presentation TVT 2015

EVEREST II at 5 Years: Lessons Learned and Implications for Future Trials

Presenter: Paul A. Grayburn, Nicole Ibrahim, David L. Brown, Ted Feldman

June 05, 2015

Presentation

Temporal trends in PCI Appropriateness: Insights from the Clinical Outcomes Assessment Program

Presenter: Steven M. Bradley

June 05, 2015

Presentation TVT 2015

Mitral Valve Implantation

Presenter: Arshad Quadri

June 05, 2015

Presentation

In-Hospital Outcomes and Hospitalization Costs of Peripheral Angioplasty vs Endovascular Stenting

Presenter: SS. Panaich

June 05, 2015

Presentation TVT 2015

Thoughtful Commentary: AS With Extreme Comorbidities (the Futile Patient)

Presenter: Howard C. Herrmann, Alec S. Vahanian, David J. Cohen

June 04, 2015

Presentation TVT 2015

Case Presentation: AS With Extreme Comorbidities (the Futile Patient)

Presenter: Howard C. Herrmann, Alec S. Vahanian, Augusto D. Pichard

June 04, 2015

Presentation TVT 2015

An Interventionalists Perspective: Will the HEART TEAM Change With a Default Transfemoral TAVR Strategy for Most Patients?

Presenter: Nicolo Piazza

June 04, 2015

Presentation TVT 2015

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Presenter: Francesco Maisano

June 04, 2015

Presentation TVT 2015

Thoughtful Commentary: Bioprosthetic Aortic Valve Failure and TAVR

Presenter: Howard C. Herrmann, Alec S. Vahanian, Vinayak Bapat

June 04, 2015

Advertisement

Slides

A Template for Transcatheter Mitral Randomized Trials: Essentials From the Mitral VARC Initiative

EVEREST II at 5 Years: Lessons Learned and Implications for Future Trials

Temporal trends in PCI Appropriateness: Insights from the Clinical Outcomes Assessment Program

Mitral Valve Implantation

In-Hospital Outcomes and Hospitalization Costs of Peripheral Angioplasty vs Endovascular Stenting

Thoughtful Commentary: AS With Extreme Comorbidities (the Futile Patient)

Case Presentation: AS With Extreme Comorbidities (the Futile Patient)

An Interventionalists Perspective: Will the HEART TEAM Change With a Default Transfemoral TAVR Strategy for Most Patients?

A Surgeons Perspective: Will the IMPLANTING TEAM Change for Intermediate- and Low-Risk Transfemoral TAVR Patients?

Thoughtful Commentary: Bioprosthetic Aortic Valve Failure and TAVR

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content